Edonerpic maleate
| Title | Journal |
|---|---|
| T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period. | Journal of psychiatric research 20120501 |
| T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. | Biochemical and biophysical research communications 20110422 |
| [Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701 |
| T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide. | British journal of pharmacology 20090601 |
| A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. | Neuropharmacology 20081001 |
| Neuroprotective effects of T-817MA against noise-induced hearing loss. | Neuroscience research 20080501 |
| T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating. | Psychopharmacology 20080401 |
| Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats. | Hippocampus 20070101 |
| T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons. | Neurochemistry international 20060101 |
| A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons. | The Journal of pharmacology and experimental therapeutics 20050701 |